Other languages Nutriband Inc.

Equities

NTRB

US67092M2089

Market Closed - OTC Markets Other stock markets 04:00:00 2024-07-02 pm EDT			5-day change	1st Jan Change
5.89 ^USD	-1.67%		+11.34%	+153.88%

Jun. 20	Nutriband Inc. Provides Product Development Update for its Lead Product Aversa Fentanyl	CI
May. 31	Nutriband Inc. Reports Earnings Results for the First Quarter Ended April 30, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nutriband Inc. Provides Product Development Update for its Lead Product Aversa Fentanyl	Jun. 20
Nutriband Inc. Reports Earnings Results for the First Quarter Ended April 30, 2024	May. 31
Nutriband Inc. Appoints Sergei Glinka to Its Board of Directors	May. 16
Nutriband Inc. Reports Earnings Results for the Full Year Ended January 31, 2024	May. 01
Nutriband Inc. Receives First Order from Fit for Life Group	Apr. 01
Nutriband Inc. Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal Patch	Mar. 27
Nutriband Inc. Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented At 2024 American Academy of Pain Medicine Annual Meeting	Mar. 25
Nutriband Inc. Announces Data on the Incidence of Transdermal Patch Abuse and Accidental Pediatric Exposure Will Be Presented At the 2024 American Academy of Pain Medicine Annual Meeting	Mar. 04
Nutriband Signs Agreement With Kindeva Drug Delivery for Aversa Fentanyl	Jan. 05
Nutriband Inc. Signs Commercial Development and Clinical Supply Agreement With Kindeva Drug Delivery for Aversa(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch	Jan. 05
Nutriband Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	Dec. 13
Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling	Nov. 28
Nutriband Signs Supplier Deal With KT Tape	Nov. 08
Nutriband Inc. Signs Supplier Agreement with KT Tape	Nov. 08
Top Premarket Decliners	Nov. 07
Sector Update: Health Care Stocks Softer Late Afternoon	23-10-11
Sector Update: Health Care	23-10-11
Nutriband Says Buprenorphine Product Has Potential to Reach Up to $130 Million in Annual US Sales	23-10-11
Nutriband Secures US Patent for Abuse Deterrent Transdermal Products	23-09-20
Nutriband Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	23-09-11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Nutriband Inc.

Equities

NTRB

US67092M2089

Other languages

Filters